Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03611556
Recruitment Status : Active, not recruiting
First Posted : August 2, 2018
Last Update Posted : March 21, 2022
Sponsor:
Information provided by (Responsible Party):
MedImmune LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 15, 2022
Estimated Study Completion Date : December 15, 2022